Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.

Research output: Contribution to journalArticle

Bibtex

@article{d90f25b79bb446ef8152fc1980207a56,
title = "Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.",
abstract = "Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.",
author = "Natalia Mochalina and Tord Juhlin and Pyotr Platonov and Peter Svensson and Mattias Wieloch",
year = "2015",
doi = "10.1016/j.thromres.2015.03.015",
language = "English",
volume = "135",
pages = "1070--1074",
journal = "Thrombosis Research",
issn = "1879-2472",
publisher = "Elsevier Ltd",
number = "6",

}